Overview

A Study of a Candidate COVID-19 Vaccine (COV001)

Status:
Active, not recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

A phase I/II single-blinded, randomised, multi-centre study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers aged 18-55 years. The vaccine will be administered intramuscularly (IM) into the deltoid region of the arm

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Oxford

Treatments:

Acetaminophen
Vaccines